image
Candel Therapeutics, Inc. CADL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.04
-0.893 %
$ 303 M
Market Cap
-4.17
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--48.89%
Net Income Estimate
60.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Candel Therapeutics, Inc.
image
CADL has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart CADL

image
$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CADL

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CADL

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)202120212022202220232023202420242025202520262026202720272028202820292029